Cancer remains one of the world’s top healthcare challenges, but over the years our ability to treat the disease has dramatically improved. In fact, there is a sense that a new generation of therapies – and particularly those harnessing the power of the immune system – could dramatically extend expected survival and even effect long-term cures in patients. Read the article here.
Cancer immunotherapy: What’s on the horizon? Read More »
Prostvac-V/F, an investigational prostate cancer vaccine regimen, does not improve overall survival among men with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer, according to the findings of the phase 3 PROSPECT trial. Read the article here.
Prostate Cancer Vaccine Found Not To Improve Survival Read More »
Researchers devised a genetic test that could identify the top one percent of men at risk of developing prostate cancer. Read the article here.
Genetic test identifies very highest risk men for prostate cancer Read More »
Scientists conducted a study which found that men with baldness at risk to develop prostate cancer. Read the article here.
Bald men are more prone to prostate cancer Read More »
Researchers showed that a subset of men who had run out of all existing options for treatment survived much longer than expected when taking immunotherapy. Read the article here.
Major trial is first to show benefits of immunotherapy in some men with prostate cancer Read More »
Treating prostate cancer could one day be as noninvasive as inhaling certain scented compounds. Read the article here.
Could Prostate Cancer Be Treated with Aromatherapy in the Future? Read More »
A new study says blue light from street lamps and home devices may increase risk of prostate cancer. Read the article here.
A discussion of radiation techniques and genomic testing in prostate cancer. Read the article here.
Expert Discusses Radiation Techniques, Genomic Testing in Prostate Cancer Read More »
Magnetic resonance imaging before biopsy for prostate-cancer detection is superior to standard transrectal ultrasonography-guided biopsy among men at risk for prostate cancer, according to a study published in the New England Journal of Medicine. Read the article here.
Prostate MRI Detects More Cancers Than Standard US-Guided Biopsy Read More »
March 2018 Awareness Night How clinical trials have changed prostate cancer care Dr. Andrew Loblaw BSc MD MSc FRCPC CIP Clinician Scientist , Ontario Association of Radiation OncologyStaff Radiation Oncologist & Clinician Scientist, Sunnybrook Health Sciences Centre Scientist, Sunnybrook Research Institute Fellow, American Society of Clinical Oncology (ASCO) Co-Chair, GU group for Cancer Care Ontario’s Program in Evidence-Based Care Previous Co-Chair, ASCO’s Genitourinary Advisory Group Professor, Department of Radiation Oncology at University of Toronto Professor,The Institute of Health Policy, Management and Evaluation (IHPME) CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 66:27 minutes
Video: “How clinical trials have changed prostate cancer care” Read More »